Kurma Partners, a Paris, France and Munich, Germany-based international specialist investment firm focused on improving human health, raised EUR 140m, completing the first closing of Biofund IV.
Biofund IV received support from cornerstone investors Eurazeo, returning investor Bpifrance and industry investor CSL, along with other undisclosed participating limited partners.
Read more on VCWire.tech, our new website dedicated to the tech venture capital industry.
FinSMEs
03/10/2024